Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Link-Asia International Medtech Group Ltd. ( (HK:1143) ) has provided an update.
Link-Asia International Medtech Group Ltd. has announced a proposed refreshment of its Scheme Mandate Limit under the 2023 Share Option Scheme. This move is intended to provide the company with greater flexibility to motivate and reward participants for their contributions to the company. The refreshment is subject to shareholder approval at the upcoming EGM and would increase the maximum number of shares that can be issued under the scheme to 10% of the issued shares as of the EGM date. The company emphasizes that this refreshment is in the best interests of both the company and its shareholders.
The most recent analyst rating on (HK:1143) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Link-Asia International Medtech Group Ltd. stock, see the HK:1143 Stock Forecast page.
More about Link-Asia International Medtech Group Ltd.
Average Trading Volume: 1,757,216
Technical Sentiment Signal: Sell
Current Market Cap: HK$93.08M
Find detailed analytics on 1143 stock on TipRanks’ Stock Analysis page.